Navigation Links
WaferGen Announces Signing of Private Financing
Date:4/14/2009

rt on Form 10-K for the year ended December 31, 2008. Investors and security holders are urged to read this document free of charge on the SEC's web site at www.sec.gov. The company does not undertake to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

    Contact:

    Vida Communication (Media)                The Trout Group (Investors)
    On Behalf of WaferGen                     On Behalf of WaferGen
    Tim Brons                                 Peter Rahmer
    415-675-7400                              646-378-2973
    tbrons@vidacommunication.com              San Francisco, CA

                                              or

                                              Christine Yang
                                              646-378-2929
                                              New York, NY


'/>"/>
SOURCE WaferGen Biosystems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
2. WaferGen to Present Data on SmartChip(TM) Real-Time PCR System at Cambridge Healthtech Institutes Quantitative PCR Conference
3. Data on WaferGens SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference
4. Data on WaferGens SmartChip Real-Time PCR System(TM) to be Presented at 16th International Molecular Medicine Tri-Conference
5. WaferGens SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program
6. WaferGen Announces Third Quarter 2008 Financial Results
7. WaferGen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
8. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
9. WaferGen to Present at the Seventh Annual BIO Investor Forum
10. WaferGen Announces Second Quarter 2008 Financial Results
11. WaferGen to Present at the Ninth Annual Beyond Genome Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... , Aug. 26, 2014   Loveland Products, ... provider of high-performance crop input products and proprietary ... that the company has acquired a controlling interest ... agricultural biotechnology company delivering biochemical-based products for efficient ... Loveland Products, fastest growing plant nutrition brands, Accomplish ...
(Date:8/26/2014)... NEW YORK , Aug. 26, 2014  That,s ... life science markets, today announced the formation of a ... strategic content development. The expanded team will combine current ... messaging areas at That,s Nice. ... Strategic Content to lead the team. Tiene was previously ...
(Date:8/26/2014)... 26, 2014 InstantGMP, Inc., the only ... a new pricing structure with increased user accounts to ... and 21 CFR Part 11 requirements. , “We want ... way we can” said Rick Soltero, President of InstantGMP. ... users allowed customers to have separate accounts for multiple ...
(Date:8/26/2014)... MA (PRWEB) August 26, 2014 ... solutions, today announced the release of Transform for ... for Electronic Data Capture (EDC) product line. It ... XClinical, and allows integration with MARVIN, the EDC ... as reducing study setup time, by allowing instantaneous ...
Breaking Biology Technology:Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 2Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 3Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 4That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3Introducing Transform for MARVIN: Providing Further Flexibility for CROs and Sponsors in Partnership with XClinical 2
... of Panzem(R) NCD and Avastin(R) May Slow ... EntreMed, Inc.,(Nasdaq: ENMD ), a ... of cancer and inflammatory diseases, today,announced the ... 2 multi-center,study combining Panzem(R) NCD with Avastin(R) ...
... YORK, Jan. 28 The Medefield Group, the ... market research, consulting,and communications companies, is pleased to ... After another year of unprecedented growth,attributed to Medefield,s ... client base, the company is adding to its,ever-growing ...
... (Nasdaq: MNKD ), focused on discovering, developing and,commercializing ... present at the Wachovia Healthcare Conference on January 30, ... Boston, MA., Interested parties can access a link ... Investor Relations section of the Company,s website at, http://www.mannkindcorp.com ...
Cached Biology Technology:EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 2EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 3EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 4Medefield Announces New Appointments to North American Business Unit 2
(Date:8/26/2014)... tent over a colony of harmful bacteria, biofilms ... Microorganisms protected in a biofilm pose a significant ... recalcitrance to treatment, and biofilm-protected bacteria account for ... humans and are 50 to 1,000 times more ... "In essence, we may have stumbled onto a ...
(Date:8/26/2014)... obtaining an unprecedented view of a type of ... of neurological illnesses, including Alzheimer,s disease, Parkinson,s disease, ... stroke. , The team of biologists at Cold ... Energy,s Advanced Photon Source at Argonne National Laboratory ... NMDA (N-methyl, D-aspartate) receptor should serve as template ...
(Date:8/26/2014)... New Zealand endemic tree has for the last 31 years ... Australian shrubs and small trees. A New Zealand botanist has ... astonishing cryptic diversity behind what was long considered a single ... journal PhytoKeys . , Known to botanists ... the many discoveries made in the north-western South Island of ...
Breaking Biology News(10 mins):Breakthrough antibacterial approach could resolve serious skin infections 2Breakthrough antibacterial approach could resolve serious skin infections 3Unprecedented detail of intact neuronal receptor offers blueprint for drug developers 2Unprecedented detail of intact neuronal receptor offers blueprint for drug developers 3And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 2And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 3
... than 10 percent each year from 2010 to 2050 ... fuels, but this is an unsustainable prospect. According to ... Governance, Economy and Ecology such a large growth rate ... otherwise each new power plant will simply cannibalize the ...
... (March 4, 2008) A unique dietary supplement called ... following experimental stroke. A nutritional supplement product, NutraStem also ... blueberry, green tea, vitamin D3 and carnosine extracts- a ... protecting against brain damage. Stroke is the third ...
... Research Council (BBSRC) funded scientists at the University of ... process of carbon dioxide fixation in plants. ... Proceedings of the National Academy of Sciences, increases our ... crop improvement and fourth generation biofuels. The mechanism, which ...
Cached Biology News:Nuclear cannibals 2Blueberry and green tea containing supplement protects against stroke damage 2Scientists uncover a novel mechanism that regulates carbon dioxide fixation in plants 2
... Serum • Beagle serum is collected from ... year of age Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium ... Alsevers N-05: ACD N-07: ...
MOUSE ANTI HUMAN MBP (67-74) Immunogen: Human myelin basic protein...
MOUSE ANTI BOVINE TROPONIN I...
Ready-to-use; 40mg/ml X-Gal and 32mg/ml IPTG...
Biology Products: